PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Making organic molecules in hydrothermal vents in the absence of life

Making organic molecules in hydrothermal vents in the absence of life
2015-06-08
(Press-News.org) In 2009, scientists from Woods Hole Oceanographic Institution embarked on a NASA-funded mission to the Mid-Cayman Rise in the Caribbean, in search of a type of deep-sea hot-spring or hydrothermal vent that they believed held clues to the search for life on other planets. They were looking for a site with a venting process that produces a lot of hydrogen because of the potential it holds for the chemical, or abiotic, creation of organic molecules like methane - possible precursors to the prebiotic compounds from which life on Earth emerged.

For more than a decade, the scientific community has postulated that in such an environment, methane and other organic compounds could be spontaneously produced by chemical reactions between hydrogen from the vent fluid and carbon dioxide (CO2). The theory made perfect sense, but showing that it happened in nature was challenging.

Now we know why: an analysis of the vent fluid chemistry proves that for some organic compounds, it doesn't happen that way.

New research by geochemists at Woods Hole Oceanographic Institution, published June 8 in the Proceedings of the National Academy of Sciences, is the first to show that methane formation does not occur during the relatively quick fluid circulation process, despite extraordinarily high hydrogen contents in the waters. While the methane in the Von Damm vent system they studied was produced through chemical reactions (abiotically), it was produced on geologic time scales deep beneath the seafloor and independent of the venting process. Their research further reveals that another organic abiotic compound is formed during the vent circulation process at adjacent lower temperature, higher pH vents, but reaction rates are too slow to completely reduce the carbon all the way to methane.

"We've really improved our understanding of the origin of abiotic hydrocarbons in all ridge-crest hydrothermal systems by identifying specifically where carbon is being transformed within the vent fluid circulation pathway," said Jill McDermott, lead author of the study and a recent graduate of the MIT/WHOI Joint Program in Oceanography. "We also have a much better sense of how quickly these reactions are occurring in natural systems - some take thousands of years, while others only take hours to days."

Methane and other organic compounds in natural waters can originate from three types of sources: living organisms, decomposition of living or dead biomass, and 'abiotic' formation via purely chemical processes with no participation from living organisms.

Finding out how methane and other organic species are formed in deep-sea hydrothermal systems is compelling because these compounds support modern day life, providing energy for microbial communities in the deep biosphere, and because of the potential role of abiotically-formed organic compounds in the origin of life.

The study, whose authors also include WHOI geochemists Jeffrey Seewald, Christopher German, and Sean Sylva, indicates that methane at the Von Damm vent field was created by a reaction between CO2 and water trapped for thousands of years within cooling volcanic rocks deep within Earth's crust. Many vent sites are tectonically active, and when tectonic shifts occur, the rocks beneath the sea floor can crack, allowing seawater to penetrate and leach methane from within the rocks. Eventually that methane is carried up to the seafloor by the circulating vent water. While this concept had previously been theorized, this paper is the first to demonstrate its importance in nature.

How the researchers determined this was a neat trick, involving balancing the vent site's CO2 budget by measuring the amount of CO2 in seawater in the vent fluid; analyzing the isotopic makeup of the CO2; and radiocarbon dating the CO2. The results of the analysis showed there has been no CO2 added, and no CO2 removed, and therefore it could not have been used to form methane.

An examination of the methane showed it was "radiocarbon dead." That meant it was older than 50,000 years and carried no modern signature, indicating the methane came from ancient geologic sources.

"We were able to use enough different but complementary lines of evidence to show that the methane formation here is a purely chemical process, and that it happens in the absence of life," said McDermott.

But why wasn't the CO2 at this site reacting with the hydrogen to create methane? That question led to an equally fascinating discovery: a reaction between CO2 and hydrogen was occurring, but it wasn't proceeding fast enough or progressing far enough to create methane.

Instead CO2 and hydrogen combined to create an "intermediate" compound called formate - an important "pre-biotic" organic compound.

The team discovered the formate when analyzing the vent fluids at cooler off-shoot vent sites at the Von Damm site and found it had less CO2 than it should have. That meant the CO2 must have been reacting to form something else. They determined the formate concentration in those fluids, and, said McDermott, "it turns out the amount of formate species that was formed in each one of these fluids, perfectly matches the amount of CO2 that was lost. It's so rare that you can actually close the budget, and figure out where all the carbon has gone." The amount of formate present also matched the amount predicted by thermodynamic models.

"This is an excellent example where hypotheses developed over the years from laboratory experiments and theoretical models could be tested and verified in nature," said co-author Seewald.

Intermediate species like formate have a lot of energy available. They're also a good energy source for microbes.

In fact, formate may be used by modern day microbes to generate methane in the subsurface biosphere. Formate may also have served as the first step toward forming reduced carbon compounds that were central to primitive biochemical pathways on early Earth.

"A particularly exciting aspect of this study is that our newest discoveries here on Earth provide a compelling 'real-world' example of just how pre-biotic chemistry could also arise elsewhere," said co-author German.

INFORMATION:

This research was supported by grants from NASA and the National Science Foundation. Additional funds were provided by the the NOAA Office of Ocean Exploration and Research and the Woods Hole Oceanographic Institution Ocean Ridge Initiative.

The Woods Hole Oceanographic Institution is a private, non-profit organization on Cape Cod, Mass., dedicated to marine research, engineering, and higher education. Established in 1930 on a recommendation from the National Academy of Sciences, its primary mission is to understand the ocean and its interaction with the Earth as a whole, and to communicate a basic understanding of the ocean's role in the changing global environment. For more information, please visit http://www.whoi.edu.


[Attachments] See images for this press release:
Making organic molecules in hydrothermal vents in the absence of life Making organic molecules in hydrothermal vents in the absence of life 2 Making organic molecules in hydrothermal vents in the absence of life 3

ELSE PRESS RELEASES FROM THIS DATE:

Hospital stays longer, more costly with poorly controlled blood sugar

2015-06-08
BOSTON -- Diabetes patients with abnormal blood sugar levels had longer, more costly hospital stays than those with glucose levels in a healthy range, according to studies presented by Scripps Whittier Diabetes Institute researchers at the 75th Scientific Sessions of the American Diabetes Association (ADA), which ends June 9 in Boston. The findings come as more patients are being admitted into U.S. hospitals with diabetes as an underlying condition. A recent UCLA public health report indicated that one of every three hospital patients admitted in California has a diagnosis ...

First CVD outcome trial of a GLP-1 agonist ginds no cardiac risk or benefit

2015-06-08
BOSTON (June 8, 2015) -- One member of a widely prescribed class of drugs used to lower blood glucose levels in people with diabetes has a neutral effect on heart failure and other cardiovascular problems, according to the first clinical trial to examine cardiovascular safety in a GLP-1 receptor agonist, presented at the American Diabetes Association's 75th Scientific Sessions. The Evaluation of Lixisenatide in Acute Coronary Syndrome (ELIXA) study also found a modest benefit for weight control, and no increase of risk for hypoglycemia or pancreatic injury in those who ...

Nanomaterial self-assembly imaged in real time

2015-06-08
A team of researchers from UC San Diego, Florida State University and Pacific Northwest National Laboratories has for the first time visualized the growth of 'nanoscale' chemical complexes in real time, demonstrating that processes in liquids at the scale of one-billionth of a meter can be documented as they happen. The achievement, which will make possible many future advances in nanotechnology, is detailed in a paper published online today in the Journal of the American Chemical Society. Chemists and material scientists will be able to use this new development in their ...

Most detailed view ever of star formation in the distant universe

Most detailed view ever of star formation in the distant universe
2015-06-08
ALMA's Long Baseline Campaign has produced a spectacularly detailed image of a distant galaxy being gravitationally lensed. The image shows a magnified view of the galaxy's star-forming regions, the likes of which have never been seen before at this level of detail in a galaxy so remote. The new observations are far more detailed than those made using the NASA/ESA Hubble Space Telescope, and reveal star-forming clumps in the galaxy equivalent to giant versions of the Orion Nebula. ALMA's Long Baseline Campaign has produced some amazing observations, and gathered unprecedentedly ...

No increased cardiovascular risk detected for new diabetes medication

2015-06-08
An international, multidisciplinary team including investigators from Brigham and Women's Hospital (BWH) has found that lixisenatide, a member of a class of glucose-lowering drugs frequently prescribed in Europe to patients with diabetes, did not increase risk of cardiovascular events including heart failure. These results - the first to be reported on the cardiovascular safety of a glucagon-like peptide 1 (GLP-1) receptor agonist - were presented today at the American Diabetes Association's 75th Scientific Sessions. "There are a large number of patients around the world ...

New study sheds light on life satisfaction and mortality risk in older adults

2015-06-08
ORANGE, Calif. -- In a study just published by researchers at Chapman University, findings showed that greater life satisfaction in adults older than 50 years of age is related to a reduced risk of mortality. The researchers also found that variability in life satisfaction across time increases risk of mortality, but only among less satisfied people. The study involved nearly 4,500 participants who were followed for up to nine years. 'Although life satisfaction is typically considered relatively consistent across time, it may change in response to life circumstances ...

Study finds weight loss in obese adults can reduce severity of asthma

2015-06-08
Glenview, Ill. (June 8, 2015)-- A Canadian study published in the June issue of the journal CHEST found weight loss reduced asthma severity as measured by airway hyperresponsiveness (AHR) in obese adults. The incidence of asthma is 1.47 times higher in obese people than nonobese people, and a three-unit increase in body mass index is associated with a 35% increase in the risk of asthma. The study supports the active treatment of comorbid obesity in individuals with asthma. The study, the first of its kind to rely on appropriate physiologic tests as diagnostic criteria ...

Dynamic whole-body PET detects more cancer

2015-06-08
Baltimore, Md. (Embargoed until 12:30 p.m. EDT, June 8, 2015) - Imaging lung cancer requires both precision and innovation. With this aim, researchers have developed a technique for clinical positron emission tomography (PET) imaging that creates advanced whole-body parametric maps, which allow quantitative evaluation of tumors and metastases throughout the body, according to research announced at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Scientists have developed a novel agent for cancer imaging that seeks and attaches ...

Theranostic PET takes on both ovarian and prostate cancer

2015-06-08
Baltimore, Md. (Embargoed until 12:30 p.m. EDT, June 8, 2015) - A first-in-human study revealed at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) shows how a powerful new drug finds and attaches itself to the ovarian and prostate cancer cells for both imaging and personalized cancer treatment. The targeted aspect of the imaging agent, called I-124 PEG-AVP0458, is a small protein (avibody) linked to polyethylene glycol (PEG) chains. The drug compound is then labeled with the radionuclide iodine-124. Drugs like PEG-AVP0458 are ...

Follow-up PET/CT more than 95 percent sensitive for non-Hodgkin lymphoma

2015-06-08
Baltimore, Md. (Embargoed until 12:30 p.m. EDT, June 8, 2015) - Non-Hodgkin lymphoma (NHL), a potentially devastating cancer of the blood and immune system, can range from relatively easy to treat to very aggressive. For more aggressive cases, post-treatment surveillance with molecular imaging could mean the early start of a new, life-saving treatment, say researchers presenting during the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). NHL is the fifth most prevalent cancer in America, according to lead author Mehdi Taghipour, MD, ...

LAST 30 PRESS RELEASES:

Scientists create ChatGPT-like AI model for neuroscience to build one of the most detailed mouse brain maps to date

AI and omics unlock personalized drugs and RNA therapies for heart disease

2023 ocean heatwave ‘unprecedented but not unexpected’

Johns Hopkins researchers develop AI to predict risk of US car crashes

New drug combination offers hope for men with advanced prostate cancer

New discovery finds gene converts insulin-producing cells into blood-sugar boosters

Powerful and precise multi-color lasers now fit on a single chip

Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing

DNA nanospring measures cellular motor power

Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research

Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

[Press-News.org] Making organic molecules in hydrothermal vents in the absence of life